Efficacy of neoadjuvant hormonal therapy combined with robot-assisted radical prostatectomy for oligometastatic prostate cancer: a multicenter retrospective study
Frontiers in Oncology · 26.03.2026 · 16
DOI: 10.3389/fonc.2026.1765517 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 26.03.2026. Verfasst von Yujie Dong und 16 weiteren Autor:innen. Beteiligte Einrichtung: Senior Department of Urology, Chinese PLA General Hospital, Beijing, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Objective
To evaluate the efficacy of neoadjuvant hormonal therapy (NHT) on perioperative and oncological outcomes in patients with oligometastatic prostate cancer (OmPCa) treated with robot-assisted radical prostatectomy (RARP) and adjuvant androgen-deprivation therapy (ADT).
Methods
In this multicenter retrospective study, 160 OmPCa patients treated from five Chinese medical centers between May 2010 and May 2023 were included: 80 received NHT followed by RARP+ADT, and 80 underwent RARP+ADT alone. We evaluated surgical information, pathological findings, biochemical progression-free survival (bPFS), radiological progression-free survival (rPFS), overall survival (OS), subsequent treatments, and ADT-related adverse events.
Results
Compared to the standard therapy (ST) group, the NHT group exhibited shorter operative time (170 vs. 200min; P = 0.030), less blood loss (100 vs. 200 mL; P = 0.022), lower positive surgical margin rate (17.50% vs. 37.50%; P = 0.005), and higher rates of pathological downstaging in T-stage (48.8% vs. 6.3%; P<0.001). More NHT patients achieved undetectable PSA (83.8% vs. 65.0%; P = 0.007) with a shorter time to PSA nadir (2 vs. 3 months; P = 0.002). After a median postoperative follow-up of 52 months, no significant differences were observed in bPFS, rPFS or OS between groups. However, subgroup analysis revealed significant interaction effects between NHT and biopsy Gleason score ≥8, seminal vesicle invasion, and clinical T stage ≥ T3 (all P-interaction<0.05), with these subgroups showing significantly improved bPFS, rPFS and OS. Furthermore, patients in the NHT group received fewer subsequent treatments (32.5% vs. 47.5%, P = 0.031), and the incidence of ADT-related adverse events was comparable between the two groups (all P >0.05).
Conclusion
NHT improves perioperative outcomes and reduces the need for subsequent salvage therapies in OmPCa patients undergoing RARP. It may offer oncological benefits, particularly those with a biopsy Gleason score ≥8 or clinical T-stage≥T3. It represents a safe and feasible neoadjuvant approach.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Senior Department of Urology, Chinese PLA General Hospital, Beijing, China.
- Department of Urology, The First Affiliated Hospital, Soochow Medical College, Soochow University, Soochow, Jiangsu, China.
- Department of Urology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Dong, Y., Li, Z., Chen, Z., Tian, Z., Chen, W., Hu, J., Jia, Y., Luo, J., Zou, N., Li, J., Liu, Q., Yang, Q., Wang, C., Xu, X., Fu, B., Zhang, X., & Wang, B. (2026). Efficacy of neoadjuvant hormonal therapy combined with robot-assisted radical prostatectomy for oligometastatic prostate cancer: a multicenter retrospective study. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1765517
Vancouver
Dong Y, Li Z, Chen Z, Tian Z, Chen W, Hu J, et al. Efficacy of neoadjuvant hormonal therapy combined with robot-assisted radical prostatectomy for oligometastatic prostate cancer: a multicenter retrospective study. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1765517
BibTeX
@article{Dong2026,
author = {Dong, Yujie and Li, Zhuoran and Chen, Zhiqiang and Tian, Zhen and Chen, Weilin and Hu, Jieping and Jia, Yuqi and Luo, Jin and Zou, Nanxin and Li, Jinqiao and Liu, Qiwei and Yang, Qiming and Wang, Chao and Xu, Xiaofeng and Fu, Bin and Zhang, Xu and Wang, Baojun},
title = {Efficacy of neoadjuvant hormonal therapy combined with robot-assisted radical prostatectomy for oligometastatic prostate cancer: a multicenter retrospective study},
journal = {Frontiers in Oncology},
year = {2026},
volume = {16},
doi = {10.3389/fonc.2026.1765517}
}
EUVIMED